Who Paid My Doc
Reline
Device Spine/Spine Surgery
PDI 00887517551702
General payments
$25,676,707
Research payments
$160,144
Through program year 2025, $25,676,707 in general payments and $160,144 in research payments were reported against Reline (Spine/Spine Surgery).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
9 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $4,185,069 | 1,717 |
| 2024 | General | $5,048,255 | 1,475 |
| 2024 | Research | $83,803 | 42 |
| 2023 | General | $5,799,645 | 1,382 |
| 2023 | Research | $24,135 | 3 |
| 2022 | General | $5,450,147 | 853 |
| 2022 | Research | $28,370 | 6 |
| 2021 | General | $5,193,591 | 751 |
| 2021 | Research | $23,836 | 1 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 28 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 39 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
6,178 general · 52 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.